Removing EPO signaling in mouse liver tumors leads to tumor regression along with sensitivity to immunotherapy.

Removing EPO signaling in mouse liver tumors leads to tumor regression along with sensitivity to immunotherapy.

University of Puerto Rico Comprehensive Cancer Center, San Juan, Puerto Rico.

MUC13 expression renders radio-resistance in human colorectal cancer cells through NRF2 signaling pathway [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting ...

New research uncovers that aging activates a new type of stem cell that rapidly produces fat cells, explaining why belly fat often expands in middle age.

Breast cancer is becoming increasingly treatable, but in some cases the disease can resurface even decades after a patient ...

School of Chemistry and Chemical Engineering, Linyi University, Linyi 276000, China School of Chemistry and Chemical Engineering, Qilu Normal University, Jinan 250200, China Key Laboratory of Advanced ...

This study presents a valuable finding on the direct cytotoxic effects of DuoHexaBody-CD37 in diffuse large B-cell lymphoma, mediated via SHP-1 activation and antibody clustering, independent of ...

From new cancer therapies to innovative military health care and technology, Harvard's cutting-edge projects are in jeopardy ...

The study, published in the Journal of Clinical Investigation, reveals that pyrvinium pamoate—a drug approved in the 1950s to ...